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OBJECTIVES: Pharmacy-managed medication assistance
programs coordinate the supply of free drugs from phar-
maceutical manufacturers to indigent patients. These pro-
grams have the potential to recoup losses incurred by the
pharmacy department but whether this offsets the per-
sonnel cost of the program has not been well established.
The purpose of this study was to conduct a cost-beneﬁt
analysis of a pharmacy-managed medication assistance
program for indigent inpatients.
METHODS: Patients were enrolled into a pharmacy-
managed medication assistance program at Hartford
Hospital by healthcare professional referral or identiﬁca-
tion through uninsured patient administrative reports.
Patients were assisted in identifying pharmaceutical man-
ufacturers’ providing free drug and completing applica-
tions. The beneﬁt was deﬁned as value of drugs procured
using hospital cost. Costs to the pharmacy consisted of
personnel cost (time administering program x wage rate
$14.52/hour + 25% employee beneﬁts). Net beneﬁt was
calculated as the value of drug procured minus personnel
costs. A threshold sensitivity analysis was performed by
varying the value of the drugs procured, personnel time
and wage rate.
RESULTS: From October through December 2001, 20
patients were enrolled into the program with 49 applica-
tions ﬁled (approval rate = 92%). Cardiovascular and
oncology/hematology comprised 63% and 18% of the
drugs provided in the program with a beneﬁt of $4,686
and $12,966, respectively. The total beneﬁt for all drugs
was $18,730. An average of 2.25 hours/day was spent
administering the program, resulting in personnel costs 
of $2,205. The net beneﬁt of the program was $16,525.
Upon sensitivity analysis, the breakeven point was
reached when drug value was reduced to $2,205, per-
sonnel time increased to 1,032 hours, and the wage rate
increased to $116/hour.
CONCLUSION: This pilot study illustrates that a phar-
macy-managed, medication assistance program for 
indigent inpatients was cost-beneﬁcial. Based on these
ﬁndings the inpatient program will be continued. An 
outpatient program will be initiated and subsequently
evaluated.
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OBJECTIVES: The Hospital for Sick Children (HSC)
Patient Amenities Fund (PAF) covers out-of-pocket medi-
cation expenses for needy families that are not provided
by private or government health plans. Recently, a sig-
niﬁcant increase in PAF expenditures for medications 
has been observed. The study objective was to examine
PAF medication expenditure trends, the reasons for fund
requests and the demographics of requesting families to
reveal limitations of existing pharmaceutical policies in
Ontario.
METHODS: The study was a retrospective descriptive
analysis of medication requests in 1998–99. Family
demographics and socio-economic status, medications
and amount requested, reasons for request, duration of
beneﬁt, type of drug plans available and government 
plan process issues were extracted from PAF request
forms, social work reports, discharge planning reports
and patient charts. Descriptive statistics were used to
analyse categorical and continuous variables. Percent
change over time in the number and dollar amount of
requests was determined.
RESULTS: Eighty-six applicants submitted 112 requests
over the two-year period. Most requests were for children
with cancer, neurological disorders and children under-
going organ transplants. The number of medication
requests increased by 67% from 1998 to 1999. Medica-
tion expenditures were $22,404 in 1999, a 39% increase
over 1998. The majority of requests (83%) came from
two-parent nuclear families. The father, mother, or both
were employed in 70% of the requests. Eighty-nine
percent of requests came from families with no private
drug plan. High deductibles, waiting time, application
form complexity and request denials were cited as prob-
lems encountered with government drug plans.
CONCLUSIONS: Whereas Ontario drug plan programs
may meet the needs of seniors and families receiving
social assistance, the need for funds to pay for medica-
tions for children persists. The current patchwork of 
government drug plans and community agencies may 
not be effective in ensuring easy and timely access to 
necessary medications.
PHP48
COST SENSITIVENESS AND PHYSICIAN
TREATMENT CHOICES
Huttin CC
Evaluation Network of Drug European Policy (Virtual Think
Tank), Brussels, Belgium
